These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17550891)

  • 1. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.
    Livermore DM; Hope R; Fagan EJ; Warner M; Woodford N; Potz N
    J Antimicrob Chemother; 2006 May; 57(5):1012-4. PubMed ID: 16531428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
    Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
    Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli.
    Rodriguez-Villalobos H; Cardentey-Reyes A; Thiroux C; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2009 Apr; 63(4):832-4. PubMed ID: 19223303
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
    Skov R; Frimodt-Moller N; Menday P; Espersen F
    Int J Antimicrob Agents; 2005 Mar; 25(3):198-204. PubMed ID: 15737512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temocillin disc diffusion susceptibility testing by EUCAST methodology.
    Vanstone GL; Dilley R; Schwenk S; Williams A; Balakrishnan I
    J Antimicrob Chemother; 2013 Nov; 68(11):2688-9. PubMed ID: 23828022
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimum inhibitory concentrations of some newly developed antimicrobials against common urinary and blood pathogens.
    el-Baz W; Hamid TA; Sabbour MS
    Chemioterapia; 1987 Jun; 6(2 Suppl):40-2. PubMed ID: 3151347
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK.
    Amin AK; Wareham DW
    Int J Antimicrob Agents; 2009 Nov; 34(5):490-1. PubMed ID: 19261447
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae.
    Patel TA; Dilley R; Williams A; Vanstone GL; Balakrishnan I
    J Antimicrob Chemother; 2013 Jul; 68(7):1685-6. PubMed ID: 23416956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance of Enterobacteriaceae to antibiotics. II. R factor in Escherichia coli (study in 210 patients)].
    Turcu T
    Bacteriol Virusol Parazitol Epidemiol (Bucur); 1974 May; 19(3):241-5. PubMed ID: 4601942
    [No Abstract]   [Full Text] [Related]  

  • 11. Quicker determination of antibiotic susceptibility in urinary tract infections.
    Rehani MM; Vaidyanathan S; Kaushal S; Aggarwal KC; Varma AD; Sharma RR; Rao MS; Bapna BC
    Indian J Pathol Microbiol; 1982 Apr; 25(2):129-34. PubMed ID: 6815075
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-Lactams without a suicide inhibitor.
    Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
    Bunnell KL; Wenzler E; Harrington AT; Danziger LH
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotype.
    Kresken M; Pfeifer Y; Werner G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106223. PubMed ID: 33166691
    [No Abstract]   [Full Text] [Related]  

  • 15. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
    Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
    Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of temocillin.
    Gupta ND; Smith RE; Balakrishnan I
    J Antimicrob Chemother; 2009 Aug; 64(2):431-3. PubMed ID: 19520716
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Clinical and Laboratory Standards Institute 2008 and 2010 guidelines in interpreting susceptibility of enterobacteriaceae isolates.
    Agrawal GN; Shevade SU
    Indian J Pathol Microbiol; 2014; 57(3):518-9. PubMed ID: 25118774
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.
    Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteriology of urinary tract infections. I. A quantitative bacteriologic study with antibiotic sensitivity of the strains isolated.
    Gohain NN; Bhujwala RA; Prakash O
    Indian J Pathol Bacteriol; 1969 Jan; 12(1):14-9. PubMed ID: 4313128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infectious drug resistance factors in Enterobacteriaceae producing urinary tract infections].
    Lachmajer M; Bugalski R
    Med Dosw Mikrobiol; 1972; 24(2):95-101. PubMed ID: 5035828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.